Taro Pharmaceutical (TARO) and Sun Pharmaceutical mutually agree to terminate their merger...

|About: Taro Pharmaceutical Indu... (TARO)|By:, SA News Editor

Taro Pharmaceutical (TARO) and Sun Pharmaceutical mutually agree to terminate their merger agreement in which Sun - a 66% owner of Taro - would have paid $39.50 for the rest of the company (Taro closed at $50.55 last night). SA author Retail Investor has covered the saga here and here, and thinks Taro could be a triple. Shares +0.9% premarket.